Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Combined Modality Therapy"" wg kryterium: Temat


Tytuł:
Inflammatory breast cancer, trimodal treatment, and mortality: Does where you live matter?
Autorzy:
Relation T; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH; Department of Surgery, MetroHealth System and Case Western Reserve University, Cleveland OH.
Li Y; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH.
Fisher JL; The Ohio State University College of Medicine, Columbus, OH; James Cancer Hospital and Solove Research Institute, Columbus, OH.
Tsung A; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH.
Oppong B; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH.
Eskander MF; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH.
Obeng-Gyasi S; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH. Electronic address: .
Pokaż więcej
Źródło:
Surgery [Surgery] 2022 Mar; Vol. 171 (3), pp. 687-692. Date of Electronic Publication: 2021 Nov 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Combined Modality Therapy*
Residence Characteristics*
Social Class*
Inflammatory Breast Neoplasms/*mortality
Inflammatory Breast Neoplasms/*therapy
Adult ; Aged ; Cohort Studies ; Female ; Humans ; Inflammatory Breast Neoplasms/pathology ; Mastectomy ; Middle Aged ; Proportional Hazards Models ; SEER Program ; Survival Rate ; United States
Czasopismo naukowe
Tytuł:
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
Autorzy:
Gonzalez-Carmona MA; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. .
Möhring C; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Mahn R; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Zhou T; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Bartels A; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Sadeghlar F; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Bolch M; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Vogt A; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Kaczmarek DJ; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Heling DJ; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Dold L; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Nattermann J; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Branchi V; Department of Surgery, University Hospital of Bonn, Bonn, Germany.
Matthaei H; Department of Surgery, University Hospital of Bonn, Bonn, Germany.
Manekeller S; Department of Surgery, University Hospital of Bonn, Bonn, Germany.
Kalff JC; Department of Surgery, University Hospital of Bonn, Bonn, Germany.
Strassburg CP; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Mohr RU; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Weismüller TJ; Department of Internal Medicine I, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 19; Vol. 12 (1), pp. 1011. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cholangiocarcinoma/*therapy
Combined Modality Therapy/*methods
Radiofrequency Ablation/*methods
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bile Duct Neoplasms/therapy ; Cholangitis ; Cholestasis/therapy ; Cisplatin/administration & dosage ; Combined Modality Therapy/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Female ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Radiofrequency Ablation/adverse effects ; Retrospective Studies ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Nanomedicine-enabled chemotherapy-based synergetic cancer treatments.
Autorzy:
Wu W; The State Key Lab of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, People's Republic of China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China.
Pu Y; Department of Medical Ultrasound, School of Medicine, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Tongji University, Shanghai, 200072, People's Republic of China.
Shi J; The State Key Lab of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, People's Republic of China. .; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China. .; Platform of Nanomedicine Translation, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2022 Jan 04; Vol. 20 (1), pp. 4. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Combined Modality Therapy*
Nanomedicine*
Antineoplastic Agents/*therapeutic use
Neoplasms/*therapy
Animals ; Humans ; Mice ; Neoplasms/pathology ; Neoplasms/physiopathology
Czasopismo naukowe
Tytuł:
Intra-arterial combination therapy for experimental acute ischemic stroke.
Autorzy:
Maniskas ME; Department of Neurosurgery, University of Kentucky, Lexington, Kentucky, USA.; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.; Department of Radiology, University of Kentucky, Lexington, Kentucky, USA.; Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.; Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.; Center for Advanced Translational Stroke Science, University of Kentucky, Lexington, Kentucky, USA.
Roberts JM; Department of Neurosurgery, University of Kentucky, Lexington, Kentucky, USA.; Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
Gorman A; Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.; Center for Advanced Translational Stroke Science, University of Kentucky, Lexington, Kentucky, USA.
Bix GJ; Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Fraser JF; Department of Neurosurgery, University of Kentucky, Lexington, Kentucky, USA.; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.; Department of Radiology, University of Kentucky, Lexington, Kentucky, USA.; Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.; Center for Advanced Translational Stroke Science, University of Kentucky, Lexington, Kentucky, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2022 Jan; Vol. 15 (1), pp. 279-286. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Combined Modality Therapy*
Infusions, Intra-Arterial*
Ischemic Stroke/*drug therapy
Animals ; Calcium Channel Blockers/administration & dosage ; Calcium Channel Blockers/pharmacology ; Mice ; Mice, Inbred C57BL ; Neuroprotective Agents/administration & dosage ; Neuroprotective Agents/pharmacology ; Piperidines/administration & dosage ; Piperidines/pharmacology ; Thiazoles/administration & dosage ; Thiazoles/pharmacology ; Treatment Outcome ; Verapamil/pharmacology
Czasopismo naukowe
Tytuł:
Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma.
Autorzy:
Takaoka, Hatsuyo (AUTHOR)
Terai, Hideki (AUTHOR)
Emoto, Katsura (AUTHOR)
Shigematsu, Lisa (AUTHOR)
Ito, Fumimaro (AUTHOR)
Saito, Ayaka (AUTHOR)
Okada, Masahiko (AUTHOR)
Ohgino, Keiko (AUTHOR)
Ikemura, Shinnosuke (AUTHOR)
Yasuda, Hiroyuki (AUTHOR)
Nakachi, Ichiro (AUTHOR)
Kawada, Ichiro (AUTHOR)
Fukunaga, Koichi (AUTHOR)
Soejima, Kenzo (AUTHOR)
Pokaż więcej
Źródło:
OncoTargets & Therapy. Sep2022, Vol. 15, p981-989. 9p.
Czasopismo naukowe
Tytuł:
Investigation of combined treatment of acupuncture and neurofeedback for improving cognitive function in mild neurocognitive disorder: A randomized, assessor-blind, pilot study.
Autorzy:
Jeong JH; Department of Oriental Neuropsychiatry, College of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Jung C; Clinical Medicine Division, Korea Institute of Oriental Medicine, Republic of Korea.
Kim J; Clinical Medicine Division, Korea Institute of Oriental Medicine, Republic of Korea.
Kim JY; Department of Oriental Neuropsychiatry, College of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Kim HS; Clinical trial center, Daejeon Korean Medicine Hospital of Daejeon University, Republic of Korea.
Park YC; Department of Internal Medicine, Daejeon Korean Medicine Hospital of Daejeon University, Republic of Korea.
Lee JH; Clinical Medicine Division, Korea Institute of Oriental Medicine, Republic of Korea.; Korean Medicine Life Science, University of Science & Technology (UST), Republic of Korea.
Jung IC; Department of Oriental Neuropsychiatry, College of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.; Clinical trial center, Daejeon Korean Medicine Hospital of Daejeon University, Republic of Korea.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2021 Sep 17; Vol. 100 (37), pp. e27218.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Acupuncture Therapy/*methods
Cognition/*drug effects
Cognitive Dysfunction/*therapy
Combined Modality Therapy/*standards
Neurofeedback/*methods
Acupuncture Therapy/standards ; Acupuncture Therapy/statistics & numerical data ; Aged ; Cognitive Dysfunction/physiopathology ; Combined Modality Therapy/methods ; Combined Modality Therapy/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Republic of Korea
Czasopismo naukowe
Tytuł:
Neck Pain and Headache After Pinealectomy: Improvement with Multimodal Chiropractic Therapies.
Autorzy:
Chu EC; New York Chiropractic and Physiotherapy Centre, EC Healthcare, Kowloon, Hong Kong.
Trager RJ; Connor Whole Health, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Nov 19; Vol. 23, pp. e937906. Date of Electronic Publication: 2022 Nov 19.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Neck Pain*/etiology
Neck Pain*/therapy
Chiropractic*
Male ; Humans ; Young Adult ; Adult ; Middle Aged ; Pinealectomy ; Quality of Life ; Headache/etiology ; Headache/therapy ; Combined Modality Therapy
Czasopismo naukowe
Tytuł:
Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors.
Autorzy:
Darragh LB; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.; Department of Immunology and Microbiology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Gadwa J; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Pham TT; Department of Otolaryngology Head and Neck Surgery, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Van Court B; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Neupert B; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Olimpo NA; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Nguyen K; Department of Pathology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Nguyen D; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Knitz MW; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Hoen M; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Corbo S; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Joshi M; Department of Pharmacology, University of Colorado Denver at Anschutz Medical campus, Aurora, CO, USA.
Zhuang Y; Department of Pediatrics, Cancer Center Biostatistics Core, University of Colorado Anschutz Medical campus, Aurora, CO, USA.
Amann M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED) Schlieren, Zurich, Switzerland.
Wang XJ; Department of Pathology and Laboratory Medicine, University of California Davis, School of Medicine, Davis, USA.; Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO, 80045, USA.
Dow S; Department of Radiation Oncology, Colorado State University, Fort Collins, Colorado. Campus, Aurora, CO, USA.
Kedl RM; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Samedi V; Department of Pathology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA.
Boss MK; Department of Radiation Oncology, Colorado State University, Fort Collins, Colorado. Campus, Aurora, CO, USA.
Karam SD; Department of Radiation Oncology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA. .; Department of Immunology and Microbiology, University of Colorado Denver at Anschutz Medical Campus, Aurora, CO, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Nov 16; Vol. 13 (1), pp. 7015. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/radiotherapy
Sentinel Lymph Node*
Humans ; Combined Modality Therapy ; Lymph Node Excision ; Immunotherapy
Czasopismo naukowe
Tytuł:
A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.
Autorzy:
Chronopoulos A; Department of Ophthalmology, Hospital of Ludwigshafen, Akademisches Lehrkrankenhaus der Johannes-Gutenberg-Universität Mainz und der Medizinischen Fakultät Mannheim der Universität Heidelberg, Ludwigshafen am Rhein, Germany.
Babst N; Department of Ophthalmology, University of Lübeck, Lübeck, Germany.
Schiemenz C; Department of Ophthalmology, University of Lübeck, Lübeck, Germany.
Schutz JS; Department of Ophthalmology, Hospital of Ludwigshafen, Akademisches Lehrkrankenhaus der Johannes-Gutenberg-Universität Mainz und der Medizinischen Fakultät Mannheim der Universität Heidelberg, Ludwigshafen am Rhein, Germany.
Heindl LM; Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Centrum für Integrierte Onkologie (CIO) Aachen-Bonn-Köln-Düsseldorf, Köln, Deutschland.
Ranjbar M; Department of Ophthalmology, University of Lübeck, Lübeck, Germany.
Kakkassery V; Department of Ophthalmology, University of Lübeck, Lübeck, Germany, .
Pokaż więcej
Źródło:
Neuro-Signals [Neurosignals] 2022 Nov 11; Vol. 30 (S1), pp. 39-58.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Retinoblastoma*/drug therapy
Retinoblastoma*/pathology
Retinal Neoplasms*/drug therapy
Retinal Neoplasms*/pathology
Humans ; Infant ; Eye Enucleation/methods ; Combined Modality Therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis.
Autorzy:
Xian F; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Department of Oncology, Nanchong Central Hospital, Nanchong, China.
Wu C; Department of Pathology, Nanchong Central Hospital, Nanchong, China.
Zhang G; Department of Oncology, Nanchong Central Hospital, Nanchong, China.
Xu G; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2022 Nov 04; Vol. 101 (44), pp. e31479.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Immunotherapy/methods ; Combined Modality Therapy
Czasopismo naukowe
Tytuł:
Investigation of optimal energy or density of a fractional CO 2 laser system in the treatment of stable non-segmental vitiligo.
Autorzy:
Yuan J; Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China. Electronic address: .
Lu Y; Department of Dermatology, General Hospital of Northern Theater Command, Shenyang, Liaoning, 110001, China.
Wu Y; Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China. Electronic address: .
Gao XH; Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Chen HD; Department of Dermatology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Pokaż więcej
Źródło:
Complementary therapies in clinical practice [Complement Ther Clin Pract] 2022 Nov; Vol. 49, pp. 101684. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Lasers, Gas*/therapeutic use
Vitiligo*/therapy
Vitiligo*/etiology
Ultraviolet Therapy*/adverse effects
Humans ; Carbon Dioxide/therapeutic use ; Treatment Outcome ; Combined Modality Therapy
Czasopismo naukowe
Tytuł:
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Autorzy:
Meirson T; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel. Electronic address: .
Neiman V; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
Sternschuss M; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
Markel G; Davidoff Cancer Center, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tannock IF; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Pokaż więcej
Źródło:
The Lancet. Oncology [Lancet Oncol] 2022 Nov; Vol. 23 (11), pp. e489.
Typ publikacji:
Letter; Comment
MeSH Terms:
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Combined Modality Therapy
Opinia redakcyjna
Tytuł:
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Autorzy:
Ganguly S; Department of Medical Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, Delhi 110029, India.
Gogia A; Department of Medical Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, Delhi 110029, India. Electronic address: .
Pokaż więcej
Źródło:
The Lancet. Oncology [Lancet Oncol] 2022 Nov; Vol. 23 (11), pp. e488.
Typ publikacji:
Letter; Comment
MeSH Terms:
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Combined Modality Therapy
Opinia redakcyjna
Tytuł:
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Autorzy:
Tarigopula V; Department of Urology, All India Institute of Medical Sciences-Bhubaneswar, Bhubaneswar 751019, India. Electronic address: .
Nayak P; Department of Urology, All India Institute of Medical Sciences-Bhubaneswar, Bhubaneswar 751019, India.
Mandal S; Department of Urology, All India Institute of Medical Sciences-Bhubaneswar, Bhubaneswar 751019, India.
Das MK; Department of Urology, All India Institute of Medical Sciences-Bhubaneswar, Bhubaneswar 751019, India.
Tripathy S; Department of Urology, All India Institute of Medical Sciences-Bhubaneswar, Bhubaneswar 751019, India.
Pokaż więcej
Źródło:
The Lancet. Oncology [Lancet Oncol] 2022 Nov; Vol. 23 (11), pp. e487.
Typ publikacji:
Letter; Comment
MeSH Terms:
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Combined Modality Therapy
Opinia redakcyjna
Tytuł:
Personalized management for Gorlin-Goltz Syndrome: Experience of combination therapy and our algorithm for treatment.
Autorzy:
Song Z; Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Li Y; Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Chung WH; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospitals, Linkou, Taipei, Keelung, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Shen C; Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Fang F; Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Institute of Dermatology, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing, China.
Bu W; Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Institute of Dermatology, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing, China.
Gao Y; Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Tao J; Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Yang L; Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Pokaż więcej
Źródło:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2022 Nov; Vol. 20 (11), pp. 1517-1519. Date of Electronic Publication: 2022 Oct 31.
Typ publikacji:
Letter
MeSH Terms:
Basal Cell Nevus Syndrome*/drug therapy
Basal Cell Nevus Syndrome*/diagnosis
Humans ; Diagnosis, Differential ; Combined Modality Therapy ; Algorithms
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz